je.st
news
U.S. lawmakers ask Gilead about Sovaldi pricing
2014-03-21 19:49:34| Biotech - Topix.net
U.S. lawmakers have asked Gilead Sciences Inc for a briefing on the price of its new hepatitis C drug Sovaldi, which some fear is too expensive at about $84,000 per patient.
Tags: pricing
lawmakers
gilead
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||